GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Oyj (OTCPK:ORINY) » Definitions » EBITDA Margin %

Orion Oyj (Orion Oyj) EBITDA Margin % : 18.15% (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Orion Oyj EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Orion Oyj's EBITDA for the three months ended in Mar. 2024 was $61 Mil. Orion Oyj's Revenue for the three months ended in Mar. 2024 was $335 Mil. Therefore, Orion Oyj's EBITDA margin for the quarter that ended in Mar. 2024 was 18.15%.


Orion Oyj EBITDA Margin % Historical Data

The historical data trend for Orion Oyj's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Oyj EBITDA Margin % Chart

Orion Oyj Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.42 31.14 27.77 36.50 27.62

Orion Oyj Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.96 16.10 26.60 29.62 18.15

Competitive Comparison of Orion Oyj's EBITDA Margin %

For the Drug Manufacturers - General subindustry, Orion Oyj's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orion Oyj's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orion Oyj's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Orion Oyj's EBITDA Margin % falls into.



Orion Oyj EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Orion Oyj's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=358.342/1297.274
=27.62 %

Orion Oyj's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=60.87/335.326
=18.15 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orion Oyj  (OTCPK:ORINY) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Orion Oyj EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Orion Oyj's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Orion Oyj (Orion Oyj) Business Description

Address
Orionintie 1, P.O. Box 65, Espoo, FIN, FI-02200
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company primarily focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. Orion mainly serves Finland but also has a presence in other European countries and North America.

Orion Oyj (Orion Oyj) Headlines

From GuruFocus

Q4 2023 Orion Oyj Earnings Call Transcript

By GuruFocus Research 02-14-2024